Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2025-12-24 @ 2:59 PM
NCT ID: NCT05155059
Eligibility Criteria: * INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 18-80 * Diagnosis of functional movement disorder made by a neurologist * Agreement to adhere to Lifestyle Considerations throughout study duration * Ability of subject to understand and the willingness to sign a written informed consent document. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Current psychosis or active suicidal ideation * History of epilepsy with the exception of febrile seizure * Patients with psychogenic non-epileptic seizure without comcomitant functional movement disorder * Any significant neurological disorders other than FMD including but not limited to multiple sclerosis, stroke, Parkinson s disease, space occupying brain lesion * Alcohol or substance use disorder * Patients who are on Buproprion (Wellbutrin) * Patients with moderate to severe cardiac disease * Any psychiatric, medical or social condition due to which, in the judgment of the PI and after any consults if indicated, participation in the study is not in the best interest of the patient. * Pregnancy
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT05155059
Study Brief:
Protocol Section: NCT05155059